The German National Program on Psoriasis Health Care 2005-2015: results and experiences
- PMID: 27048503
- PMCID: PMC4940437
- DOI: 10.1007/s00403-016-1637-8
The German National Program on Psoriasis Health Care 2005-2015: results and experiences
Abstract
In 2005, the first national psoriasis survey in Germany revealed large deficits in health care particularly in patients with moderate to severe disease. The consecutive goal was to improve health care for psoriasis countrywide. For this, a large-scale national program was initiated starting with a comprehensive analysis of structures and processes of care for psoriasis. Patient burden, economic impact and barriers to care were systematically analyzed. In order to optimize routine care, a S3 guideline, a set of outcomes measures and treatment goals, were developed. Implementation was enforced by the German Psoriasis Networks (PsoNet) connecting the most dedicated dermatologists. The annual National Conference on Health Care in Psoriasis established in 2009 consented National Health Care Goals in Psoriasis 2010-2015 and defined a set of quality indicators, which are monitored on a regular basis. Currently 28 regional networks including more than 800 dermatologists are active. Between 2005 and 2014 7 out of 8 quality indicators have markedly improved, and regional disparities were resolved. e.g., mean PASI (Psoriasis Area Severity Index) dropped from 11.4 to 8.1 and DLQI (Dermatology Life Quality Index) from 8.6 to 5.9. A decade of experience indicates that a coordinated nationwide psoriasis program based on goal orientation can contribute to better quality of care and optimized outcomes.
Keywords: Health Care Program; Long-term outcomes; Psoriasis; Quality of health care.
Figures
Similar articles
-
Quality of psoriasis care in Germany: results of the national health care study "PsoHealth3".Arch Dermatol Res. 2016 Aug;308(6):401-8. doi: 10.1007/s00403-016-1651-x. Epub 2016 May 20. Arch Dermatol Res. 2016. PMID: 27206971
-
Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators.Dermatology. 2009;219(1):54-8. doi: 10.1159/000218161. Epub 2009 May 7. Dermatology. 2009. PMID: 19420901
-
Quality of psoriasis care in Germany--results of the national study PsoHealth 2007.J Dtsch Dermatol Ges. 2008 Aug;6(8):640-5. doi: 10.1111/j.1610-0387.2008.06807.x. J Dtsch Dermatol Ges. 2008. PMID: 18801145 English, German.
-
Decision-Analytic Modeling for Time-Effectiveness of the Sequence of Induction Treatments for Moderate to Severe Plaque Psoriasis.JAMA Dermatol. 2019 Dec 1;155(12):1380-1389. doi: 10.1001/jamadermatol.2019.2941. JAMA Dermatol. 2019. PMID: 31617856 Free PMC article.
-
Definition of treatment goals for moderate to severe psoriasis: a European consensus.Arch Dermatol Res. 2011 Jan;303(1):1-10. doi: 10.1007/s00403-010-1080-1. Epub 2010 Sep 21. Arch Dermatol Res. 2011. PMID: 20857129 Free PMC article.
Cited by
-
PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries.Acta Derm Venereol. 2023 Aug 31;103:adv6532. doi: 10.2340/actadv.v103.6532. Acta Derm Venereol. 2023. PMID: 37649411 Free PMC article.
-
Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis.Int J Mol Sci. 2022 Aug 19;23(16):9336. doi: 10.3390/ijms23169336. Int J Mol Sci. 2022. PMID: 36012602 Free PMC article.
-
The impact of the first COVID-19 wave on office-based dermatological care in Germany: a focus on diagnosis, therapy and prescription of biologics.Eur J Dermatol. 2022 Apr 1;32(2):195-206. doi: 10.1684/ejd.2022.4222. Eur J Dermatol. 2022. PMID: 35866899 Free PMC article.
-
Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data.Arch Dermatol Res. 2018 Aug;310(6):475-483. doi: 10.1007/s00403-018-1825-9. Epub 2018 Mar 24. Arch Dermatol Res. 2018. PMID: 29574575 Free PMC article. Review.
-
A New Classification of the Severity of Psoriasis: What's Moderate Psoriasis?Life (Basel). 2021 Jun 29;11(7):627. doi: 10.3390/life11070627. Life (Basel). 2021. PMID: 34209585 Free PMC article.
References
-
- Augustin M, Alvaro-Gracia JM, Bagot M, Hillmann O, van de Kerkhof PCM, Kobelt G, Maccarone M, Naldi L, Schellekens H. Psoriasis white paper—a framework for improving the quality of care for people with psoriasis. J Eur Acad Dermatol Venereol. 2012;26(Suppl 4):1–16. doi: 10.1111/j.1468-3083.2012.04576.x. - DOI - PubMed
-
- Augustin M, Chapnick J, Gupta S, Buesch K, Radtke M. Psoriasis verursacht hohe Kosten, mindert die Produktivität am Arbeitsplatz und verringert die Lebensqualität. Akt Dermatol. 2011;37:353–359. doi: 10.1055/s-0030-1256636. - DOI
-
- Augustin M, Kaufmann R, Strömer K, Christophers E, von Zitzewitz H (eds) (2014) PsoNet Magazin, Hamburg
Related articles recently published in Archives of Dermatological Research (selected by the journal’s editorial staff)
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical